Annual Gross Profit
$490.31 M
+$22.78 M+4.87%
December 31, 2023
Summary
- As of February 12, 2025, PCRX annual gross profit is $490.31 million, with the most recent change of +$22.78 million (+4.87%) on December 31, 2023.
- During the last 3 years, PCRX annual gross profit has risen by +$177.99 million (+56.99%).
- PCRX annual gross profit is now at all-time high.
Performance
PCRX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$129.71 M
-$4.05 M-3.03%
September 30, 2024
Summary
- As of February 12, 2025, PCRX quarterly gross profit is $129.71 million, with the most recent change of -$4.05 million (-3.03%) on September 30, 2024.
- Over the past year, PCRX quarterly gross profit has increased by +$5.53 million (+4.46%).
- PCRX quarterly gross profit is now -3.03% below its all-time high of $133.76 million, reached on June 30, 2024.
Performance
PCRX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$516.72 M
+$5.53 M+1.08%
September 30, 2024
Summary
- As of February 12, 2025, PCRX TTM gross profit is $516.72 million, with the most recent change of +$5.53 million (+1.08%) on September 30, 2024.
- Over the past year, PCRX TTM gross profit has increased by +$49.93 million (+10.70%).
- PCRX TTM gross profit is now at all-time high.
Performance
PCRX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
PCRX Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.9% | +4.5% | +10.7% |
| 3 y3 years | +57.0% | +6.4% | +18.6% |
| 5 y5 years | +95.8% | +6.4% | +18.6% |
PCRX Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +22.2% | -3.0% | +17.9% | at high | +28.8% |
| 5 y | 5-year | at high | +57.0% | -3.0% | +143.8% | at high | +71.1% |
| alltime | all time | at high | >+9999.0% | -3.0% | +5577.6% | at high | >+9999.0% |
Pacira BioSciences Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $129.71 M(-3.0%) | $516.72 M(+1.1%) |
| Jun 2024 | - | $133.76 M(+11.7%) | $511.19 M(+2.5%) |
| Mar 2024 | - | $119.70 M(-10.4%) | $498.69 M(+1.7%) |
| Dec 2023 | $490.31 M(+4.9%) | $133.55 M(+7.6%) | $490.31 M(+5.0%) |
| Sep 2023 | - | $124.18 M(+2.4%) | $466.80 M(+1.6%) |
| Jun 2023 | - | $121.26 M(+8.9%) | $459.41 M(+0.5%) |
| Mar 2023 | - | $111.32 M(+1.2%) | $456.93 M(-2.3%) |
| Dec 2022 | $467.53 M(+16.5%) | $110.04 M(-5.8%) | $467.53 M(-2.1%) |
| Sep 2022 | - | $116.79 M(-1.7%) | $477.68 M(+5.2%) |
| Jun 2022 | - | $118.78 M(-2.6%) | $453.96 M(+4.2%) |
| Mar 2022 | - | $121.92 M(+1.4%) | $435.52 M(+8.5%) |
| Dec 2021 | $401.28 M(+28.5%) | $120.19 M(+29.1%) | $401.28 M(+6.5%) |
| Sep 2021 | - | $93.07 M(-7.2%) | $376.77 M(+1.5%) |
| Jun 2021 | - | $100.34 M(+14.4%) | $371.19 M(+14.5%) |
| Mar 2021 | - | $87.68 M(-8.4%) | $324.05 M(+3.8%) |
| Dec 2020 | $312.32 M(-0.6%) | $95.68 M(+9.4%) | $312.32 M(+1.7%) |
| Sep 2020 | - | $87.49 M(+64.5%) | $307.16 M(+1.7%) |
| Jun 2020 | - | $53.20 M(-30.0%) | $302.05 M(-7.4%) |
| Mar 2020 | - | $75.95 M(-16.1%) | $326.26 M(+3.8%) |
| Dec 2019 | $314.31 M(+25.5%) | $90.52 M(+9.9%) | $314.31 M(+6.6%) |
| Sep 2019 | - | $82.38 M(+6.4%) | $294.93 M(+6.5%) |
| Jun 2019 | - | $77.40 M(+20.9%) | $276.93 M(+5.4%) |
| Mar 2019 | - | $64.01 M(-10.0%) | $262.72 M(+4.9%) |
| Dec 2018 | $250.43 M(+26.0%) | $71.14 M(+10.5%) | $250.43 M(+5.6%) |
| Sep 2018 | - | $64.38 M(+1.9%) | $237.08 M(+6.9%) |
| Jun 2018 | - | $63.19 M(+22.2%) | $221.80 M(+7.8%) |
| Mar 2018 | - | $51.72 M(-10.5%) | $205.74 M(+3.5%) |
| Dec 2017 | $198.72 M(+19.5%) | $57.78 M(+17.7%) | $198.72 M(+4.5%) |
| Sep 2017 | - | $49.11 M(+4.2%) | $190.21 M(+14.4%) |
| Jun 2017 | - | $47.12 M(+5.4%) | $166.31 M(+0.3%) |
| Mar 2017 | - | $44.70 M(-9.3%) | $165.77 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2016 | $166.27 M(-6.1%) | $49.28 M(+95.5%) | $166.27 M(-0.4%) |
| Sep 2016 | - | $25.20 M(-45.9%) | $166.88 M(-11.2%) |
| Jun 2016 | - | $46.59 M(+3.1%) | $187.99 M(+3.5%) |
| Mar 2016 | - | $45.20 M(-9.4%) | $181.62 M(+2.5%) |
| Dec 2015 | $177.16 M(+47.4%) | $49.89 M(+7.7%) | $177.16 M(+4.2%) |
| Sep 2015 | - | $46.31 M(+15.1%) | $170.09 M(+9.4%) |
| Jun 2015 | - | $40.22 M(-1.3%) | $155.44 M(+9.1%) |
| Mar 2015 | - | $40.74 M(-4.9%) | $142.43 M(+18.5%) |
| Dec 2014 | $120.23 M(+290.6%) | $42.82 M(+35.3%) | $120.23 M(+29.8%) |
| Sep 2014 | - | $31.66 M(+16.3%) | $92.59 M(+33.4%) |
| Jun 2014 | - | $27.21 M(+46.8%) | $69.40 M(+41.3%) |
| Mar 2014 | - | $18.54 M(+22.0%) | $49.12 M(+59.6%) |
| Dec 2013 | $30.78 M(+343.2%) | $15.19 M(+79.4%) | $30.78 M(+88.0%) |
| Sep 2013 | - | $8.47 M(+22.2%) | $16.37 M(+130.5%) |
| Jun 2013 | - | $6.93 M(+3434.2%) | $7.10 M(+21.7%) |
| Mar 2013 | - | $196.00 K(-74.8%) | $5.83 M(-16.0%) |
| Dec 2012 | $6.95 M(-761.4%) | $778.00 K(-197.1%) | $6.95 M(+82.8%) |
| Sep 2012 | - | -$801.00 K(-114.2%) | $3.80 M(-26.9%) |
| Jun 2012 | - | $5.66 M(+332.3%) | $5.20 M(+8423.0%) |
| Mar 2012 | - | $1.31 M(-155.3%) | $61.00 K(-105.8%) |
| Dec 2011 | -$1.05 M(-145.9%) | -$2.37 M(-495.3%) | -$1.05 M(-175.2%) |
| Sep 2011 | - | $599.00 K(+15.0%) | $1.40 M(-20.5%) |
| Jun 2011 | - | $521.00 K(+165.8%) | $1.76 M(+21.8%) |
| Mar 2011 | - | $196.00 K(+136.1%) | $1.44 M(-36.8%) |
| Dec 2010 | $2.29 M(-15.5%) | $83.00 K(-91.3%) | $2.29 M(-24.0%) |
| Sep 2010 | - | $959.00 K(+365.5%) | $3.01 M(-2.7%) |
| Jun 2010 | - | $206.00 K(-80.2%) | $3.09 M(+7.1%) |
| Mar 2010 | - | $1.04 M(+28.8%) | $2.88 M(+56.2%) |
| Dec 2009 | $2.71 M(-176.5%) | $806.00 K(-22.6%) | $1.85 M(+77.4%) |
| Sep 2009 | - | $1.04 M | $1.04 M |
| Dec 2008 | -$3.54 M | - | - |
FAQ
- What is Pacira BioSciences annual gross profit?
- What is the all time high annual gross profit for Pacira BioSciences?
- What is Pacira BioSciences annual gross profit year-on-year change?
- What is Pacira BioSciences quarterly gross profit?
- What is the all time high quarterly gross profit for Pacira BioSciences?
- What is Pacira BioSciences quarterly gross profit year-on-year change?
- What is Pacira BioSciences TTM gross profit?
- What is the all time high TTM gross profit for Pacira BioSciences?
- What is Pacira BioSciences TTM gross profit year-on-year change?
What is Pacira BioSciences annual gross profit?
The current annual gross profit of PCRX is $490.31 M
What is the all time high annual gross profit for Pacira BioSciences?
Pacira BioSciences all-time high annual gross profit is $490.31 M
What is Pacira BioSciences annual gross profit year-on-year change?
Over the past year, PCRX annual gross profit has changed by +$22.78 M (+4.87%)
What is Pacira BioSciences quarterly gross profit?
The current quarterly gross profit of PCRX is $129.71 M
What is the all time high quarterly gross profit for Pacira BioSciences?
Pacira BioSciences all-time high quarterly gross profit is $133.76 M
What is Pacira BioSciences quarterly gross profit year-on-year change?
Over the past year, PCRX quarterly gross profit has changed by +$5.53 M (+4.46%)
What is Pacira BioSciences TTM gross profit?
The current TTM gross profit of PCRX is $516.72 M
What is the all time high TTM gross profit for Pacira BioSciences?
Pacira BioSciences all-time high TTM gross profit is $516.72 M
What is Pacira BioSciences TTM gross profit year-on-year change?
Over the past year, PCRX TTM gross profit has changed by +$49.93 M (+10.70%)